Stockscreener 앱 받기
31.70
1.61%
-0.52
시간 외 거래:
31.74
0.04
+0.13%
전일 마감가:
$32.22
열려 있는:
$32.09
하루 거래량:
1.91M
Relative Volume:
1.60
시가총액:
$5.85B
수익:
$520.18M
순이익/손실:
$-348.13M
주가수익비율:
-16.51
EPS:
-1.92
순현금흐름:
$-176.18M
1주 성능:
-1.12%
1개월 성능:
-5.29%
6개월 성능:
+1.34%
1년 성능:
-36.93%
1일 변동 폭
$31.18
$32.44
1주일 범위
$31.18
$33.21
52주 변동 폭
$27.34
$51.77
Legend Biotech Corp Adr Stock (LEGN) Company Profile
LEGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LEGN
Legend Biotech Corp Adr
|
31.70 | 5.95B | 520.18M | -348.13M | -176.18M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Legend Biotech Corp Adr Stock (LEGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-10-08 | 개시 | Redburn Atlantic | Buy |
| 2024-06-17 | 개시 | Truist | Buy |
| 2024-05-24 | 재확인 | H.C. Wainwright | Buy |
| 2024-05-23 | 개시 | Deutsche Bank | Buy |
| 2024-04-17 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2024-04-03 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-03-13 | 개시 | Raymond James | Outperform |
| 2023-12-19 | 개시 | Scotiabank | Sector Perform |
| 2023-11-06 | 개시 | Goldman | Buy |
| 2023-05-25 | 개시 | William Blair | Mkt Perform |
| 2023-05-22 | 개시 | Daiwa Securities | Buy |
| 2023-03-29 | 개시 | H.C. Wainwright | Buy |
| 2023-03-24 | 개시 | RBC Capital Mkts | Outperform |
| 2022-12-06 | 개시 | UBS | Buy |
| 2022-11-02 | 개시 | Evercore ISI | Outperform |
| 2022-11-01 | 개시 | Cowen | Outperform |
| 2022-10-31 | 개시 | Guggenheim | Neutral |
| 2022-06-17 | 개시 | BMO Capital Markets | Outperform |
| 2022-03-15 | 개시 | Barclays | Overweight |
| 2022-01-31 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-21 | 개시 | Piper Sandler | Overweight |
| 2021-05-18 | 개시 | BTIG Research | Buy |
| 2020-07-01 | 개시 | JP Morgan | Overweight |
| 2020-07-01 | 개시 | Jefferies | Buy |
| 2020-06-30 | 개시 | Morgan Stanley | Overweight |
모두보기
Legend Biotech Corp Adr 주식(LEGN)의 최신 뉴스
Legend Biotech (NASDAQ:LEGN) Research Coverage Started at Cantor Fitzgerald - Defense World
Legend Biotech Corporation Sponsored ADR $LEGN Shares Sold by Public Employees Retirement System of Ohio - Defense World
GAMMA Investing LLC Has $30,000 Holdings in Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
Voya Investment Management LLC Takes Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Harbor Capital Advisors Inc. Grows Stock Holdings in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Rhumbline Advisers Buys 391 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Advisors Asset Management Inc. Has $673,000 Holdings in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Compared to Estimates, Legend Biotech (LEGN) Q4 Earnings: A Look at Key Metrics - MSN
Alliancebernstein L.P. Purchases 32,101 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Legend Biotech stock rating reiterated at Outperform by RBC Capital - Investing.com
Legend Biotech Corporation Sponsored ADR $LEGN Stake Decreased by Cinctive Capital Management LP - MarketBeat
Nomura Holdings Inc. Purchases New Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Legend Biotech at Morgan Stanley Conference: CARVYKTI’s Global Impact - Investing.com
Legend Biotech (NASDAQ:LEGN) Shares Up 5.4%Here's Why - MarketBeat
Legend Biotech Mulling 2nd Listing in HK, Singapore, or London: Wire - AASTOCKS.com
Northern Trust Corp Has $9.73 Million Stake in Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
Rexel (OTCMKTS:RXLSF) Stock Passes Above Two Hundred Day Moving Average – What’s Next? - Defense World
Cantor Fitzgerald Expects Weaker Earnings for Legend Biotech - MarketBeat
Legend Biotech’s SWOT analysis: carvykti success drives stock potential amid challenges - Investing.com India
Nuveen LLC Purchases Shares of 170,186 Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Brokers Issue Forecasts for Legend Biotech FY2025 Earnings - Defense World
Price T Rowe Associates Inc. MD Sells 78,302 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Legend Biotech (NASDAQ:LEGN) Receives “Overweight” Rating from Cantor Fitzgerald - Defense World
Resolute Capital Asset Partners LLC Buys New Stake in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
170,186 Shares in Legend Biotech Corporation Sponsored ADR $LEGN Purchased by Nuveen LLC - Defense World
Legend Biotech (NASDAQ:LEGN) Price Target Raised to $78.00 at JPMorgan Chase & Co. - Defense World
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Receives $72.38 Average PT from Brokerages - Defense World
PNC Financial Services Group Inc. Buys 3,238 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
Swiss National Bank Has $5.53 Million Holdings in National Storage Affiliates Trust $NSA - Defense World
Occidental Petroleum (NYSE:OXY) & Berry (NASDAQ:BRY) Critical Survey - Defense World
Legend Biotech Corporation Sponsored ADR $LEGN Stock Holdings Boosted by Swiss National Bank - Defense World
US Bancorp DE Lowers Position in Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
Contrasting Hillenbrand (NYSE:HI) and IperionX (NASDAQ:IPX) - Defense World
Legend Biotech names Carlos Santos as new CFO - Investing.com
Legend Biotech’s SWOT analysis: carvykti drives growth as stock faces competition - Investing.com
Legend Biotech’s SWOT analysis: carvykti drives growth as stock faces competition By Investing.com - Investing.com South Africa
Company News for Aug 12, 2025 - NewsBreak: Local News & Alerts
Legend Biotech (NASDAQ:LEGN) Price Target Raised to $83.00 at Morgan Stanley - Defense World
Legend Biotech (NASDAQ:LEGN) Receives Outperform Rating from Royal Bank Of Canada - Defense World
Legend Biotech stock price target raised to $77 by RBC Capital - Investing.com South Africa
Earnings call transcript: Legend Biotech Q2 2025 reveals strong revenue growth - Investing.com
Earnings call transcript: Legend Biotech Q2 2025 reveals strong revenue growth By Investing.com - Investing.com South Africa
Legend Biotech Q2 2025 slides: CARVYKTI sales surge 136%, adjusted profit achieved - Investing.com India
XTX Topco Ltd Takes $307,000 Position in Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) - Defense World
Legend Biotech Corp Adr (LEGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.74%
자본화:
|
볼륨(24시간):